Polymyositis–dermatomyositis and infections

References

• Kim B, Kaistha SD, Rouse BT. Viruses and autoimmunity. Autoimmunity 2005; 38: 559–565
   PubMed Web of Science ®Google Scholar
• Soulas P, Woods A, Jaulhac B, Knapp AM, Pasquali JL, Martin T, Korganow AS. Autoantigen, innate immunity and T cells cooperate to break B cell tolerance during bacterial infection. J Clin Invest 2005; 115: 2257–2267
   PubMed Web of Science ®Google Scholar
• Winau F, Kaufmann SHE, Schaible UE. Apoptosis paves the detour path for CD8T cell activation against intracellular bacteria. Cell Microbiol 2004; 6: 599–607
   PubMed Web of Science ®Google Scholar
• Mahoney JA, Rosen A. Apoptosis and autoimmunity. Curr Opin Immunol 2005; 17: 583–588
   PubMed Web of Science ®Google Scholar
• Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocytes-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998; 41: 1241–1250
   PubMed Web of Science ®Google Scholar
• Zandman-Goddard G, Shoenfeld Y. Infections and SLE. Autoimmunity 2005; 38: 473–485
   PubMed Web of Science ®Google Scholar
• Ferri C, Zignego AL. Relation between infection and autoimmunity in mixed cryoglobulinemia. Curr Opin Rheumatol 2002; 12: 53–60
   Google Scholar
• Guilherme L, Dulphy N, Douay C, Coelho V, Cunha-Neto E, Oshiro SE, Assis RV, Tanaka AC, Pomerantzeff PM, Charron D, Toubert A, Kalil J. Molecular evidence for antigen-driven immune responses in cardiac lesions of rheumatic heart disease patients. Int Immunol 2000; 12: 1063–1074
   PubMed Web of Science ®Google Scholar
• Askanas V, Engel WK. Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: Current concepts of diagnosis and pathogenesis. Curr Opin Rheumatol 1998; 10: 530–542
   PubMedGoogle Scholar
• Brouwer R, Hengstman GJ, Vree Egberts W, Ehrfeld H, Bozic B, Ghirardello A, Grondal G, Hietarinta M, Isenberg D, Kalden JR, Lundberg I, Moutsopoulos H, Roux-Lombard P, Vencovsky J, Wikman A, Seelig HP, van Engelen BG, van Venrooij WJ. Autoantibodies profiles in the sera of European patients with myositis. Ann Rheum Dis 2001; 60: 116–123
   PubMed Web of Science ®Google Scholar
• Zampieri S, Ghirardello A, Iaccarino L, Tarricone E, Gambari PF, Doria A. Anti-Jo-1 antibodies. Autoimmunity 2005; 38: 73–78
   PubMed Web of Science ®Google Scholar
• Ghirardello A, Zampieri S, Iaccarino L, Tarricone E, Bendo R, Gambari PF, Doria A. Anti-Mi-2 antibodies. Autoimmunity 2005; 38: 79–83
   PubMed Web of Science ®Google Scholar
• Vassilopoulos D, Chalasani P, Jurado RJ, Workowski K, Agudelo CA. Musculoskeletal infections in patients with human immunodeficiency virus infection. Medicine 1997; 76: 284–294
   PubMedGoogle Scholar
• Mathews MB, Bernstein RM. Myositis autoantibodies inhibits histydil-tRNA synthetase. A model for autoimmunity. Nature 1986; 2: 605–607
   Google Scholar
• Bolz DD, Weis JJ. Molecular mimicry to Borrelia burgdorferi: Pathway to autoimmunity?. Autoimmunity 2004; 37: 387–392
   PubMed Web of Science ®Google Scholar
• Molina V, Shoenfeld Y. Infections, vaccines and other environmental triggers of autoimmunity. Autoimmunity 2005; 38: 235–245
   PubMed Web of Science ®Google Scholar
• Walker EJ, Jeffrey PD. Polymyositis and molecular mimicry, a mechanism of autoimmunity. Lancet 1986; 13: 605–607
   Google Scholar
• Albani S. Infection and molecular mimicry in autoimmune disease of childhood. Clin Exp Rheumatol 1994; 12(Suppl. 10)S35–S41
   PubMedGoogle Scholar
• Manta P, Kalfakis N, Vassilopoulos D. Evidence for seasonal variation in polymyositis. Neuroepidemiology 1989; 8: 262–265
   PubMedGoogle Scholar
• Mastaglia FL, Phillips AB. Idiopathic inflammatory myopathies: Epidemiology, classification and diagnostic criteria. Rheum Dis Clin North Am 2002; 723–741
   PubMedGoogle Scholar
• Leff RL, Burgess SH, Miller FW, Love LA, Targoff IN, Dalakas MC, Joffe MM, Plotz PH. Distinct seasonal patterns in the onset of adult inflammatory myopathy in patients with anti Jo-1 and anti-Signal recognition particle autoantibodies. Arthritis Rheum 1991; 34: 1391–1397
   PubMedGoogle Scholar
• Phillips BA, Zilko PJ, Garlepp MJ, Mastaglia FL. Seasonal occurrence of relapses in inflammatory myopathies: A preliminary study. J Neurol 2002; 249: 441–444
   PubMedGoogle Scholar
• Plots PH. Autoantibodies are anti-idiotype antibodies to viral antibodies. Lancet 1983; II: 824–826
   Google Scholar
• Blechynden LM, Lawson MA, Tabarias H, Garlepp MJ, Sherman J, Raben N, Lawson CM. Myositis induced by naked DNA immunization with the gene for the histidyl-tRNA synthetase. Hum Gene Ther 1997; 8: 1469–1480
   PubMedGoogle Scholar
• Tam PE, Schimidt AM, Ytterberg SR, Messner RP. Duration of virus persistence and its relationship to inflammation during chronic phase of Coxsackie virus B1-induced murine polymyositis. J Lab Clin Med 1994; 123: 346–356
   PubMed Web of Science ®Google Scholar
• Cronin ME, Love LA, Miller FW, McClintock PR. The natural history of encephalomyocarditis virus-induced myositis and myocarditis in mice. Viral persistence demonstrated by in situ hybridisation. J Exp Med 1988; 168: 1639–1648, Plotz PH.
   PubMedGoogle Scholar
• Gauntt CJ, Higdon AL, Arizpe HM, Tamayo MR, Crawley R, Henkel RD, Pereira ME, Tracy SM, Cunningham MW. Epitopes shared between Coxsackie virus B3 (CVB3) and normal heart tissue contribute to CVB3-induced murine myocarditis. Clin Immunol Immunopathol 1993; 68: 129–134
   PubMedGoogle Scholar
• Neu N, Craig SW, Rose NR, Alvarez F, Beisel KW. Coxsackievirus induced myocarditis in mice: Cardiac myosin autoantibodies do not cross-react with the virus. Clin Exp Immunol 1987; 69: 566–574
   PubMed Web of Science ®Google Scholar
• Wolfgram LJ, Beisel KW, Rose NR. Heart specific autoantibodies following murine coxsackievirus B3 myocarditis. J Exp Med 1985; 161: 1112–1121
   PubMed Web of Science ®Google Scholar
• Moslemi AR, Lindberg C, Oldfors A. Analysis of multiple mitochondrial DNA deletions in inclusion body myositis. Mol Cell Biochem 1997; 174: 277–281
   PubMedGoogle Scholar
• Whitton JL, Feuer R. Myocarditis, microbes and autoimmunity. Autoimmunity 2004; 37: 375–386
   Web of Science ®Google Scholar
• Leff RL, Love LA, Miller FW, Greenberg SJ, Klein EA, Dalakas MC, Plotz PH. Viruses in idiopathic inflammatory myopathies: Absence of candidate viral genomes in muscle. Lancet 1992; 339: 1192–1194
   PubMed Web of Science ®Google Scholar
• Chevrel G, Borsotti JP, Miossec P. Lack of evidence for a direct involvement for muscle infection by parvovirus B19 in the pathogenesis of inflammatory myopathies: A follow-up study. Rheumatology 2003; 42: 349–352
   PubMedGoogle Scholar
• Chevrel G, Calvet A, Belin V, Miossec P. Dermatomyositis associated with the presence of parvovirus B19 DNA in muscle. Rheumatology 2000; 39: 1037–1039
   PubMed Web of Science ®Google Scholar
• Travers RL, Hughes GR, Sewall JR. Coxsackie B neutralization titers in polymyositis/dermatomyositis. Lancet 1977; 1: 1268
   PubMedGoogle Scholar
• Bowles NE, Dubowitz V, Sewry CA, Archard LC. Dermatomyositis, polymyositis and coxsackie-B-virus infection. Lancet 1987; I: 1004–1007
   Google Scholar
• Youself GE, Isenberg DA, Mowbray JF. Detection of enterovirus specific RNA sequences in muscle biopsy specimens from patients with adult onset of myositis. Ann Rheum Dis 1990; 49: 310–315
   PubMedGoogle Scholar
• Fox SA, Finklestone E, Robbins PD, Mastaglia FL, Swanson NR. Search for persistent enterovirus infection of muscle in inflammatory myopathies. J Neurol Sci 1994; 125: 70–76
   PubMedGoogle Scholar
• Jongen PJH, Zoll GJ, Beaumont M, Melchers WJG, van de Putte LBA, Galama JMD. Polymyositis and dermatomyositis: No persistence of enteroviruses or encephalomyocarditis virus RNA in muscle. Ann Rheum Dis 1993; 52: 575–578
   PubMedGoogle Scholar
• Johnson RW, Williams FM, Kazi S, Dimachie MM, Reveille JD. Human immunodeficiency virus-associated polymyositis: A longitudinal study outcome. Arthritis Rheum 2003; 49: 172–178
   PubMedGoogle Scholar
• Morgan OS, Rodgers-Johnson P, Mora C, Char G. HTLV-1 and polymyositis in Jamaica. Lancet 1989; 2: 1184–1187
   PubMed Web of Science ®Google Scholar
• Saito M, Higuchi I, Saito A, Izumo S, Usuku K, Bangham CRM, Osame M. Molecular analysis of T cell clonotypes in muscle-infiltrating lymphocytes from patients with human T lymphotropic virus type 1 polymyositis. JID 2002; 186: 1231–1241
   PubMedGoogle Scholar
• Callen JP. Dermatomyositis. Lancet 2000; 355: 53–57
   PubMed Web of Science ®Google Scholar
• Marie I, Hachulla E, Cherin P, Hellot M-F, Herson S, Levesque H, Hatron P-Y. Opportunistic infection in polymyositis and dermatomyositis. Arthitis Rheum 2005; 53: 155–165
   PubMed Web of Science ®Google Scholar
• Danko K, Ponyi A, Constantin T, Borgulya G, Szegedi G. Lomg term survival of patients with idiopathic inflammatory myopathies according to clinical features. A longitudinal study of 162 cases. Medicine (Baltimore) 2004; 83: 35–42
   PubMed Web of Science ®Google Scholar
• Juarez M, Misischia R, Alarcon GS. Infections in systemic connective tissue diseases: Systemic lupus erythematosus, scleroderma and polymyositis/dermatomyositis. Rheum Dis Clin North Am 2003; 29: 163–184
   PubMed Web of Science ®Google Scholar
• Voguier M, Fouere S, De La Salmoniere P, Rabian C, Lebbe C, Dubertret L, Morel P, Bachelez H. Peripheral blood lymphocyte subset counts in patients with dermatomyositis. Clinical correlations and changes following therapy. Medicine (Baltimore) 2003; 82: 82–86
   PubMedGoogle Scholar
• Moore EC, Cohen F, Douglas SD, Gutta V. Staphyolococcal infections in childhood dermatomyositis-association with the development of calcinosis, raised IgE concentration and granulocyte chemotactic defect. Ann Rheum Dis 1992; 51: 378–383
   PubMedGoogle Scholar
• Schwarz ML. Thoracic manifestation of systemic autoimmune diseases. The lung in polymyositis. Clin Chest Med 1998; 19: 701–712
   PubMed Web of Science ®Google Scholar
• Nagaoka S, Tani K, Ishigatsubo Y, Chiba J, Kato K, Matsunaga K, Narita M, Igarashi T, Okubo T. Herpes zoster in patients with polymyositis and dermatomyositis. Kansenshogaku Zasshi 1990; 64: 1394–1399
   PubMedGoogle Scholar